Key facts
- This page summarizes Astorga Jeannette Ferran's Form 4 filing for Zoetis Inc. (ZTS).
- 2 reported transactions and 8 derivative rows are listed below.
- Accepted by SEC: 19 Feb 2026, 20:54.
Astorga Jeannette Ferran - 18 Feb 2026 Form 4 Insider Report for Zoetis Inc. (ZTS)
- Reporting relationship
- Executive Vice President
- Issuer ticker
- ZTS
- Reported as of
- 18 Feb 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Feb 2026, 20:54:07 UTC
- Prior SEC filing
- 10 Feb 2026
- Next SEC filing
- 23 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brenda Santuccio, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Astorga Jeannette Ferran filed Form 4 for Zoetis Inc. (ZTS) on 19 Feb 2026.
Change
- Previous filing in this sequence was filed on 10 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001900614
Primary reporting owner
Ferran Astorga Jeannette
- Relationship
- Executive Vice President
- Address
- C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY
- Signature
- /s/ Brenda Santuccio, as Attorney-in-Fact
- Signature date
- 19 Feb 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZTS
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +2,197
- Change %
- Price
- $0.000000
- Shares after
- 2,197
- Date
- 18 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,197
- Exercise price
- Footnotes
- F1, F2, F3, F4
ZTS
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +8,693
- Change %
- Price
- $0.000000
- Shares after
- 8,693
- Date
- 18 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,693
- Exercise price
- $129.13
- Footnotes
- F7, F8, F9
ZTS
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,295
- Date
- 18 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,295
- Exercise price
- Footnotes
- F1, F2, F4, F5
ZTS
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 207
- Date
- 18 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 207
- Exercise price
- Footnotes
- F1, F2, F4, F6
ZTS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,973
- Date
- 18 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,973
- Exercise price
- $156.64
- Footnotes
- F7, F9, F10
ZTS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,328
- Date
- 18 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,328
- Exercise price
- $196.14
- Footnotes
- F7, F9, F11
ZTS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,353
- Date
- 18 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,353
- Exercise price
- $162.07
- Footnotes
- F7, F9, F12
ZTS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,057
- Date
- 18 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,057
- Exercise price
- Footnotes
- F9, F13, F14, F15
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 15 footnotes
Footnote F1
Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
Footnote F2
Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
Footnote F3
One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Footnote F4
Not applicable.
Footnote F5
One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Footnote F6
One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Footnote F7
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
Footnote F8
One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026.
Footnote F9
Each option expires on the tenth anniversary of the date of grant.
Footnote F10
One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025.
Footnote F11
One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.
Footnote F12
One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023.
Footnote F13
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan
Footnote F14
1,304 options granted September 30, 2020 at an exercise price of $165.37 per option; 925 options granted February 10, 2021 at an exercise price of $160.62 per option; and 1,828 options granted February 8, 2022 at an exercise price of $201.30 per option.
Footnote F15
Each option vested on the third anniversary of the date of grant.